Nisa Investment Advisors’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
VCM
MA
BFM
Nisa Investment Advisors's MXCT Position: Q1 2026 in Review
Nisa Investment Advisors increased its MaxCyte (MXCT) stake by 162% in Q1 2026, buying an estimated $362 and bringing the position to 628 shares worth $441. The position accounts for ﹤0.01% of the portfolio, ranked #2879.
Nisa Investment Advisors first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $55.5K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.
- Nisa Investment Advisors held 628 shares of MaxCyte worth $441 as of Q1 2026.
- Nisa Investment Advisors bought 388 MaxCyte shares in Q1 2026, an estimated $362.
- MaxCyte made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2879 holding.
- Nisa Investment Advisors first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
- Nisa Investment Advisors's MaxCyte position peaked at $55.5K in Q4 2023.
- 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.